Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma
Elevated YKT6 expression is related to poor prognosis of LUAD patients. YKT6 can serve as a novel biomarker for LUAD diagnosis and prognosis. Cell proliferation, migration and invasion was impaired with increased apoptosis upon YKT6 silencing in lung cancer cells. In summary, this study comprehensively uncovered that YKT6 could be identified as a potential prognostic and diagnostic biomarker in LUAD.
Authors
- Lina Wang (ORCID: https://orcid.org/0000-0003-1457-0015)
- Liming Zhang (ORCID: https://orcid.org/0000-0003-1497-1556)
- Shaoqiang Wang (ORCID: https://orcid.org/0000-0002-7539-5970)
Institutions
- Weifang People's Hospital (CN)
- Affiliated Hospital of Jining Medical University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1186/s12885-024-12975-3
- Citations
- 10
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 2.34
Funders
- National Natural Science Foundation of China